Cargando…
Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study
OBJECTIVES: Estimate and compare the risk of mortality in patients whose antidiabetic therapy is modified to include pioglitazone compared with an alternative antidiabetic medication at the same stage of disease progression. DESIGN: Retrospective cohort study. SETTING: Pooled analysis of clinical da...
Autores principales: | Strongman, Helen, Korhonen, Pasi, Williams, Rachael, Bahmanyar, Shahram, Hoti, Fabian, Christopher, Solomon, Majak, Maila, Kool-Houweling, Leanne, Linder, Marie, Dolin, Paul, Heintjes, Edith M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530248/ https://www.ncbi.nlm.nih.gov/pubmed/28761650 http://dx.doi.org/10.1136/bmjdrc-2016-000364 |
Ejemplares similares
-
Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study
por: Strongman, Helen, et al.
Publicado: (2018) -
Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries
por: Korhonen, Pasi, et al.
Publicado: (2016) -
Evaluation of exposure to pioglitazone and risk of prostate cancer: a nested case–control study
por: Boxall, Naomi, et al.
Publicado: (2016) -
Multidatabases in Health Care systems
por: Bell, D A
Publicado: (1993) -
Pioglitazone, bladder cancer, and detection bias
por: Dolin, Paul
Publicado: (2014)